- Miller, Matthew S;
- Rialdi, Alexander;
- Ho, Jessica Sook Yuin;
- Tilove, Micah;
- Martinez-Gil, Luis;
- Moshkina, Natasha P;
- Peralta, Zuleyma;
- Noel, Justine;
- Melegari, Camilla;
- Maestre, Ana M;
- Mitsopoulos, Panagiotis;
- Madrenas, Joaquín;
- Heinz, Sven;
- Benner, Chris;
- Young, John AT;
- Feagins, Alicia R;
- Basler, Christopher F;
- Fernandez-Sesma, Ana;
- Becherel, Olivier J;
- Lavin, Martin F;
- van Bakel, Harm;
- Marazzi, Ivan
The human helicase senataxin (SETX) has been linked to the neurodegenerative diseases amyotrophic lateral sclerosis (ALS4) and ataxia with oculomotor apraxia (AOA2). Here we identified a role for SETX in controlling the antiviral response. Cells that had undergone depletion of SETX and SETX-deficient cells derived from patients with AOA2 had higher expression of antiviral mediators in response to infection than did wild-type cells. Mechanistically, we propose a model whereby SETX attenuates the activity of RNA polymerase II (RNAPII) at genes stimulated after a virus is sensed and thus controls the magnitude of the host response to pathogens and the biogenesis of various RNA viruses (e.g., influenza A virus and West Nile virus). Our data indicate a potentially causal link among inborn errors in SETX, susceptibility to infection and the development of neurologic disorders.